A detailed history of Assetmark, Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Assetmark, Inc holds 60,395 shares of JNJ stock, worth $10 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
60,395
Previous 56,284 7.3%
Holding current value
$10 Million
Previous $8.9 Million 0.85%
% of portfolio
0.03%
Previous 0.03%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$144.38 - $157.78 $593,546 - $648,633
4,111 Added 7.3%
60,395 $8.83 Million
Q1 2024

May 06, 2024

BUY
$155.22 - $162.74 $707,182 - $741,443
4,556 Added 8.81%
56,284 $8.9 Million
Q4 2023

Feb 09, 2024

BUY
$145.6 - $158.88 $154,336 - $168,412
1,060 Added 2.09%
51,728 $8.11 Million
Q3 2023

Oct 27, 2023

SELL
$155.75 - $174.48 $112,918 - $126,497
-725 Reduced 1.41%
50,668 $7.89 Million
Q2 2023

Aug 11, 2023

BUY
$154.35 - $166.11 $206,674 - $222,421
1,339 Added 2.68%
51,393 $8.51 Million
Q1 2023

May 05, 2023

BUY
$151.05 - $180.26 $1.11 Million - $1.32 Million
7,341 Added 17.19%
50,054 $7.76 Million
Q4 2022

Feb 10, 2023

BUY
$160.2 - $179.79 $1.15 Million - $1.29 Million
7,152 Added 20.11%
42,713 $7.55 Million
Q3 2022

Nov 01, 2022

BUY
$161.33 - $179.52 $1.1 Million - $1.22 Million
6,816 Added 23.71%
35,561 $5.81 Million
Q2 2022

Aug 03, 2022

BUY
$168.19 - $186.01 $2.39 Million - $2.64 Million
14,192 Added 97.52%
28,745 $5.1 Million
Q1 2022

May 13, 2022

BUY
$158.14 - $179.59 $352,019 - $399,767
2,226 Added 18.06%
14,553 $2.58 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $273,033 - $302,940
1,751 Added 16.56%
12,327 $2.11 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $159,077 - $176,777
-985 Reduced 8.52%
10,576 $1.71 Million
Q2 2021

Aug 16, 2021

BUY
$159.48 - $171.07 $163,148 - $175,004
1,023 Added 9.71%
11,561 $1.9 Million
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $198,991 - $221,624
1,300 Added 14.07%
10,538 $1.73 Million
Q4 2020

Feb 10, 2021

SELL
$137.11 - $157.38 $7,129 - $8,183
-52 Reduced 0.56%
9,238 $1.45 Million
Q3 2020

Nov 13, 2020

BUY
$140.38 - $153.83 $322,312 - $353,193
2,296 Added 32.83%
9,290 $1.38 Million
Q2 2020

Aug 11, 2020

SELL
$128.81 - $155.51 $1.28 Million - $1.54 Million
-9,906 Reduced 58.62%
6,994 $984,000
Q1 2020

May 12, 2020

BUY
$111.14 - $153.99 $980,143 - $1.36 Million
8,819 Added 109.13%
16,900 $2.22 Million
Q4 2019

Feb 11, 2020

BUY
$127.5 - $146.44 $27,667 - $31,777
217 Added 2.76%
8,081 $1.18 Million
Q3 2019

Nov 13, 2019

BUY
$126.95 - $142.14 $206,293 - $230,977
1,625 Added 26.05%
7,864 $1.02 Million
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $136,133 - $149,721
1,038 Added 19.96%
6,239 $869,000
Q1 2019

May 14, 2019

SELL
$125.72 - $139.79 $11,189 - $12,441
-89 Reduced 1.68%
5,201 $727,000
Q4 2018

Feb 13, 2019

SELL
$122.84 - $147.84 $23.2 Million - $27.9 Million
-188,791 Reduced 97.27%
5,290 $683,000
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $458,113 - $538,371
3,768 Added 1.98%
194,081 $26.8 Million
Q2 2018

Aug 01, 2018

BUY
$119.4 - $131.76 $344,349 - $379,995
2,884 Added 1.54%
190,313 $23.1 Million
Q1 2018

May 16, 2018

SELL
$125.1 - $148.14 $259,082 - $306,797
-2,071 Reduced 1.09%
187,429 $24 Million
Q4 2017

Feb 13, 2018

SELL
$131.22 - $143.62 $4.71 Million - $5.16 Million
-35,911 Reduced 15.93%
189,500 $26.5 Million
Q3 2017

Nov 08, 2017

SELL
$129.47 - $135.38 $17.5 Million - $18.3 Million
-135,312 Reduced 37.51%
225,411 $29.3 Million
Q2 2017

Aug 15, 2017

BUY
N/A
9,067 Added 2.58%
360,723 $47.7 Million
Q1 2017

Sep 15, 2017

BUY
N/A
29,442 Added 9.14%
351,656 $43.8 Million
Q4 2016

Sep 15, 2017

BUY
N/A
45,604 Added 16.49%
322,214 $37.1 Million
Q3 2016

Sep 15, 2017

BUY
N/A
151,226 Added 120.61%
276,610 $32.7 Million
Q2 2016

Sep 15, 2017

BUY
N/A
9,091 Added 7.82%
125,384 $15.2 Million
Q1 2016

Sep 15, 2017

BUY
N/A
7,842 Added 7.23%
116,293 $12.6 Million
Q4 2015

Sep 15, 2017

BUY
N/A
108,451
108,451 $11.1 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.